A CRISPR picture – patent filing and litigation trendsManaging Intellectual PropertyPatent filing trends for the gene editing technology indicate a near 200% increase globally between 2013 and 2015, and a continuing boom since. Patrick Wingrove investi… Continue reading
Stanford University NewsStanford scientists combine CRISPR and DNA barcoding to track cancer growthStanford University NewsThe team achieved this result using CRISPR-Cas9 – a powerful gene-editing tool that can easily replace, modify, or delete genetic… Continue reading
Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen …Dove Medical PressBackground: CD19-chimericantigen receptor (CAR) modified T cells (CD19-CAR T cells) have been well documented to poss… Continue reading
Analyzing ArQule (ARQL) and Editas Medicine (EDIT)registrarjournal.comIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) compl… Continue reading
Critical Survey: OpGen (OPGN) versus Editas Medicine (EDIT)The Ledger GazetteIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (… Continue reading
The Independent |
Gene therapy is now available, but could cost millions over a lifetime, says scientists
The Independent If you were born with a rare form of blindness, there is now a treatment for you that may restore your eyesight. That’s because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may … |
WIRED |
A Journal Retracted A Controversial Paper About CRISPR. The Damage Might Already Be Done.
Futurism A scientific journal just retracted a controversial study that claimed the gene editing tool CRISPR causes a number of unintended mutations, but it may be too late to undo the damage the paper caused. Let’s walk it back a second. In May 2017, well … A Flawed Study Shows How Little We Understand Crispr’s Effects …WIRED Scientific journal officially retracts controversial CRISPR studyNew Atlas Paper on Off-Target CRISPR Effects PulledGenomeWeb Business Insider –Daily Mail –IFLScience –bioRxiv all 18 news articles » |